Ozempic (semaglutide) Disease area(s): Metabolic diseases Manufacturer(s): Novo Nordisk 2024 Sales (USD): $17.45 billion Why it sold so well: Novo Nordisks GLP-1 blockbuster for type 2 diabetes continued its impressive growth in 2024, with sales increasing by 26% year-over-year to DKK 120.3 billion ($17.45 billion)
Claims billed with D50.9 are closely reviewed when clinical notes or laboratory results support a specific cause, such as blood loss, pregnancy, or malabsorption
Prices dramatically below market rate, semaglutide at $15/vial , tirzepatide at $25/vial , almost certainly indicate an underdosed or counterfeit product
If nausea worsens, discontinue and consult your PlexusDx clinician
According to Penn Medicine, the exact cause of NAION isnt fully understood, but its more common in people who are middle-aged or older, and the shape of someones optic nerve may even play a role in their risk of eye stroke